Spravato, a depression treatment derived from club drug ketamine, was looking like a dud. Its recent success now shows a path forward for psychedelic-based medicines.
Related Posts
CBS Interview on Israel Triggers Fight at Network; Shari Redstone Weighs In
An anchor critiqued Ta-Nehisi Coates’s new book, and Paramount’s controlling shareholder objected to how the network handled the matter.
Conan O’Brien to Host the Oscars
The former late-night host will succeed Jimmy Kimmel, an Academy Awards regular.
Basic Materials Roundup: Market Talk
Read about Anglo American, BHP, Iluka and more in the latest Market Talks covering Basic Materials.